Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon-Kyoung Sung

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Journal of Rheumatic Diseases|July 21, 2023
Epidemiology of Rheumatoid Arthritis in KoreaHyoungyoung Kim, Yoon-Kyoung Sung
The Korean Journal of Internal Medicine|February 15, 2019
A paradigm shift in studies based on rheumatoid arthritis clinical registriesSoo-Kyung Cho, Yoon-Kyoung Sung
International Journal of Clinical Pharmacology and Therapeutics|July 20, 2021
Comparison of the efficacy and safety of tocilizumab, sarilumab, and sirukumab in comparison with adalimumab as monotherapy in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trialsYoon-Kyoung Sung, Young Ho Lee
Zeitschrift Fur Rheumatologie|November 11, 2021
The lessebo effect in randomized controlled trials of rituximab in patients with rheumatoid arthritis: a meta-analysisYoon-Kyoung Sung, Young Ho Lee
International Journal of Clinical Pharmacology and Therapeutics|April 16, 2021
Comparison of the efficacy and safety of tofacitinib and mavrilimumab in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trialsYoon-Kyoung Sung, Young Ho Lee
Zeitschrift Fur Rheumatologie|July 9, 2021
Placebo and nocebo responses in randomized controlled trials of non-tumor necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumor necrosis factor inhibitors: A meta-analysisYoon-Kyoung Sung, Young Ho Lee
International Journal of Clinical Pharmacology and Therapeutics|October 8, 2021
Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trialsYoon-Kyoung Sung, Young Ho Lee
Endocrinology and Metabolism (Seoul, Korea)|June 16, 2026
Update on Glucocorticoid-Induced Osteoporosis: Emerging Therapeutic StrategiesSoo-Kyung Cho, Yoon-Kyoung Sung
Journal of Clinical Pharmacy and Therapeutics|February 18, 2021
Comparative effectiveness and safety of non-tumour necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumour necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trialsYoon-Kyoung Sung, Young Ho Lee
Zeitschrift Fur Rheumatologie|March 9, 2021
Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis : A meta-analysisYoon-Kyoung Sung, Young Ho Lee
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Journal of Rheumatic Diseases|July 21, 2023
Epidemiology of Rheumatoid Arthritis in KoreaHyoungyoung Kim, Yoon-Kyoung Sung
The Korean Journal of Internal Medicine|February 15, 2019
A paradigm shift in studies based on rheumatoid arthritis clinical registriesSoo-Kyung Cho, Yoon-Kyoung Sung
International Journal of Clinical Pharmacology and Therapeutics|July 20, 2021
Comparison of the efficacy and safety of tocilizumab, sarilumab, and sirukumab in comparison with adalimumab as monotherapy in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trialsYoon-Kyoung Sung, Young Ho Lee
Zeitschrift Fur Rheumatologie|November 11, 2021
The lessebo effect in randomized controlled trials of rituximab in patients with rheumatoid arthritis: a meta-analysisYoon-Kyoung Sung, Young Ho Lee
International Journal of Clinical Pharmacology and Therapeutics|April 16, 2021
Comparison of the efficacy and safety of tofacitinib and mavrilimumab in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trialsYoon-Kyoung Sung, Young Ho Lee
Zeitschrift Fur Rheumatologie|July 9, 2021
Placebo and nocebo responses in randomized controlled trials of non-tumor necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumor necrosis factor inhibitors: A meta-analysisYoon-Kyoung Sung, Young Ho Lee
International Journal of Clinical Pharmacology and Therapeutics|October 8, 2021
Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trialsYoon-Kyoung Sung, Young Ho Lee
Endocrinology and Metabolism (Seoul, Korea)|June 16, 2026
Update on Glucocorticoid-Induced Osteoporosis: Emerging Therapeutic StrategiesSoo-Kyung Cho, Yoon-Kyoung Sung
Journal of Clinical Pharmacy and Therapeutics|February 18, 2021
Comparative effectiveness and safety of non-tumour necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumour necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trialsYoon-Kyoung Sung, Young Ho Lee
Zeitschrift Fur Rheumatologie|March 9, 2021
Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis : A meta-analysisYoon-Kyoung Sung, Young Ho Lee
Pageof 20